PMC:7242013 / 13015-13236 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T40","span":{"begin":30,"end":40},"obj":"Body_part"},{"id":"T41","span":{"begin":41,"end":44},"obj":"Body_part"}],"attributes":[{"id":"A40","pred":"fma_id","subj":"T40","obj":"http://purl.org/sig/ont/fma/fma82740"},{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"On May 1, 2020, remdesivir, a nucleotide RNA polymerase inhibitor, was authorized by the US Food and Drug Administration under Emergency Use Authorization for treatment of those patients hospitalized with severe COVID‐19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"393","span":{"begin":178,"end":186},"obj":"Species"},{"id":"396","span":{"begin":16,"end":26},"obj":"Chemical"},{"id":"399","span":{"begin":212,"end":220},"obj":"Disease"}],"attributes":[{"id":"A393","pred":"tao:has_database_id","subj":"393","obj":"Tax:9606"},{"id":"A396","pred":"tao:has_database_id","subj":"396","obj":"MESH:C000606551"},{"id":"A399","pred":"tao:has_database_id","subj":"399","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"On May 1, 2020, remdesivir, a nucleotide RNA polymerase inhibitor, was authorized by the US Food and Drug Administration under Emergency Use Authorization for treatment of those patients hospitalized with severe COVID‐19."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T165","span":{"begin":212,"end":220},"obj":"Disease"}],"attributes":[{"id":"A165","pred":"mondo_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"On May 1, 2020, remdesivir, a nucleotide RNA polymerase inhibitor, was authorized by the US Food and Drug Administration under Emergency Use Authorization for treatment of those patients hospitalized with severe COVID‐19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T108","span":{"begin":28,"end":29},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"On May 1, 2020, remdesivir, a nucleotide RNA polymerase inhibitor, was authorized by the US Food and Drug Administration under Emergency Use Authorization for treatment of those patients hospitalized with severe COVID‐19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T49","span":{"begin":16,"end":26},"obj":"Chemical"},{"id":"T50","span":{"begin":30,"end":40},"obj":"Chemical"},{"id":"T51","span":{"begin":41,"end":65},"obj":"Chemical"},{"id":"T52","span":{"begin":56,"end":65},"obj":"Chemical"}],"attributes":[{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_36976"},{"id":"A51","pred":"chebi_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/CHEBI_37416"},{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"On May 1, 2020, remdesivir, a nucleotide RNA polymerase inhibitor, was authorized by the US Food and Drug Administration under Emergency Use Authorization for treatment of those patients hospitalized with severe COVID‐19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T145","span":{"begin":0,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"On May 1, 2020, remdesivir, a nucleotide RNA polymerase inhibitor, was authorized by the US Food and Drug Administration under Emergency Use Authorization for treatment of those patients hospitalized with severe COVID‐19."}